Amicus Therapeutics, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for FOLD, updated each market day.
FOLD AI Sentiment
AI predicts Amicus Therapeutics, Inc stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Amicus Therapeutics, Inc
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Sector
Exchange
Market Cap
$4,543,590,302
Cap Tier
Employees
511
Headquarters
PRINCETON, NJ
Listed Since
May 31, 2007
Website
FOLD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FOLD Volatility
Amicus Therapeutics, Inc has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
